Matches in SemOpenAlex for { <https://semopenalex.org/work/W60205234> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W60205234 endingPage "1166" @default.
- W60205234 startingPage "1166" @default.
- W60205234 abstract "1166 Objectives Radium-223 chloride (Alpharadin) is a first-in-class targeted alpha- pharmaceutical with a potent and highly targeted antitumor effect on bone metastases and a benign safety profile. We evaluated the biodistribution and dosimetry of this agent in the context of its clinical safety profile. Methods 6 patients with bone-metastatic CRPC received 2 doses of 100 kBq/kg 6 weeks apart. Blood, urine and faeces were collected before and at regular intervals after injection. Planar whole body quantitative gamma camera imaging determined biodistribution. Radiation dose was calculated with adjustments for GI tract, heart wall, red marrow (RM) and osteogenic cells (OC). It was also taken into consideration that the product emits short range, high energy alpha particles. Safety and tolerability were evaluated separately in 292 patients in Phase I/II trials treated with activities from 5 - 250 kBq/kg (single and multiple doses). Results The biodistribution study showed that Radium-223 was rapidly eliminated from blood and taken up in bone (~60% at 4hr) or excreted into the small intestine. There was Conclusions Radium-223 chloride was rapidly sequestered to bone/bone metastases and excreted predominantly via the GI tract. The favourable haematological toxicity profile offers a clinically relevant advantage compared to beta radiopharmaceuticals, and is consistent with the short range of alpha particles" @default.
- W60205234 created "2016-06-24" @default.
- W60205234 creator A5003388016 @default.
- W60205234 creator A5013126792 @default.
- W60205234 creator A5023771110 @default.
- W60205234 creator A5038049517 @default.
- W60205234 creator A5043648973 @default.
- W60205234 creator A5049536851 @default.
- W60205234 creator A5078161354 @default.
- W60205234 creator A5081540359 @default.
- W60205234 date "2010-05-01" @default.
- W60205234 modified "2023-09-23" @default.
- W60205234 title "Radium-223 chloride, a first-in-class alpha-pharmaceutical for patients with castration resistant prostate cancer (CRPC) and bone metastases. Dosimetry and pharmacokinetic analysis" @default.
- W60205234 hasPublicationYear "2010" @default.
- W60205234 type Work @default.
- W60205234 sameAs 60205234 @default.
- W60205234 citedByCount "0" @default.
- W60205234 crossrefType "journal-article" @default.
- W60205234 hasAuthorship W60205234A5003388016 @default.
- W60205234 hasAuthorship W60205234A5013126792 @default.
- W60205234 hasAuthorship W60205234A5023771110 @default.
- W60205234 hasAuthorship W60205234A5038049517 @default.
- W60205234 hasAuthorship W60205234A5043648973 @default.
- W60205234 hasAuthorship W60205234A5049536851 @default.
- W60205234 hasAuthorship W60205234A5078161354 @default.
- W60205234 hasAuthorship W60205234A5081540359 @default.
- W60205234 hasConcept C112705442 @default.
- W60205234 hasConcept C121608353 @default.
- W60205234 hasConcept C126322002 @default.
- W60205234 hasConcept C126894567 @default.
- W60205234 hasConcept C151730666 @default.
- W60205234 hasConcept C185592680 @default.
- W60205234 hasConcept C197934379 @default.
- W60205234 hasConcept C202751555 @default.
- W60205234 hasConcept C2776139714 @default.
- W60205234 hasConcept C2777807558 @default.
- W60205234 hasConcept C2778375690 @default.
- W60205234 hasConcept C2779343474 @default.
- W60205234 hasConcept C2780007613 @default.
- W60205234 hasConcept C2780026642 @default.
- W60205234 hasConcept C2780192828 @default.
- W60205234 hasConcept C2989005 @default.
- W60205234 hasConcept C55493867 @default.
- W60205234 hasConcept C71924100 @default.
- W60205234 hasConcept C75088862 @default.
- W60205234 hasConcept C86803240 @default.
- W60205234 hasConcept C98274493 @default.
- W60205234 hasConceptScore W60205234C112705442 @default.
- W60205234 hasConceptScore W60205234C121608353 @default.
- W60205234 hasConceptScore W60205234C126322002 @default.
- W60205234 hasConceptScore W60205234C126894567 @default.
- W60205234 hasConceptScore W60205234C151730666 @default.
- W60205234 hasConceptScore W60205234C185592680 @default.
- W60205234 hasConceptScore W60205234C197934379 @default.
- W60205234 hasConceptScore W60205234C202751555 @default.
- W60205234 hasConceptScore W60205234C2776139714 @default.
- W60205234 hasConceptScore W60205234C2777807558 @default.
- W60205234 hasConceptScore W60205234C2778375690 @default.
- W60205234 hasConceptScore W60205234C2779343474 @default.
- W60205234 hasConceptScore W60205234C2780007613 @default.
- W60205234 hasConceptScore W60205234C2780026642 @default.
- W60205234 hasConceptScore W60205234C2780192828 @default.
- W60205234 hasConceptScore W60205234C2989005 @default.
- W60205234 hasConceptScore W60205234C55493867 @default.
- W60205234 hasConceptScore W60205234C71924100 @default.
- W60205234 hasConceptScore W60205234C75088862 @default.
- W60205234 hasConceptScore W60205234C86803240 @default.
- W60205234 hasConceptScore W60205234C98274493 @default.
- W60205234 hasLocation W602052341 @default.
- W60205234 hasOpenAccess W60205234 @default.
- W60205234 hasPrimaryLocation W602052341 @default.
- W60205234 hasRelatedWork W1490430881 @default.
- W60205234 hasRelatedWork W176293627 @default.
- W60205234 hasRelatedWork W1904298553 @default.
- W60205234 hasRelatedWork W1980543089 @default.
- W60205234 hasRelatedWork W2004836798 @default.
- W60205234 hasRelatedWork W2019280002 @default.
- W60205234 hasRelatedWork W2171244455 @default.
- W60205234 hasRelatedWork W2255315609 @default.
- W60205234 hasRelatedWork W2291461205 @default.
- W60205234 hasRelatedWork W2346874390 @default.
- W60205234 hasRelatedWork W2544324436 @default.
- W60205234 hasRelatedWork W2584297339 @default.
- W60205234 hasRelatedWork W2750573724 @default.
- W60205234 hasRelatedWork W2782192630 @default.
- W60205234 hasRelatedWork W2791808636 @default.
- W60205234 hasRelatedWork W2800553690 @default.
- W60205234 hasRelatedWork W2990979064 @default.
- W60205234 hasRelatedWork W3114638455 @default.
- W60205234 hasRelatedWork W3162773921 @default.
- W60205234 hasRelatedWork W9425051 @default.
- W60205234 hasVolume "51" @default.
- W60205234 isParatext "false" @default.
- W60205234 isRetracted "false" @default.
- W60205234 magId "60205234" @default.
- W60205234 workType "article" @default.